Skip to main content

editorial

. 1983 Jan 22;286(6361):246–247. doi: 10.1136/bmj.286.6361.246

Artificial blood.

PMCID: PMC1546526 PMID: 6402055

246

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Clark L. C., Jr, Gollan F. Survival of mammals breathing organic liquids equilibrated with oxygen at atmospheric pressure. Science. 1966 Jun 24;152(3730):1755–1756. doi: 10.1126/science.152.3730.1755. [DOI] [PubMed] [Google Scholar]
Geyer R. P. Fluorocarbon-polyol artificial blood substitutes. N Engl J Med. 1973 Nov 15;289(20):1077–1082. doi: 10.1056/NEJM197311152892008. [DOI] [PubMed] [Google Scholar]
Glogar D. H., Kloner R. A., Muller J., DeBoer L. W., Braunwald E., Clark L. C., Jr Fluorocarbons reduce myocardial ischemic damage after coronary occlusion. Science. 1981 Mar 27;211(4489):1439–1441. doi: 10.1126/science.7466402. [DOI] [PubMed] [Google Scholar]
Peerless S. J., Ishikawa R., Hunter I. G., Peerless M. J. Protective effect of Fluosol-DA in acute cerebral ischemia. Stroke. 1981 Sep-Oct;12(5):558–563. doi: 10.1161/01.str.12.5.558. [DOI] [PubMed] [Google Scholar]
Tremper K. K., Friedman A. E., Levine E. M., Lapin R., Camarillo D. The preoperative treatment of severely anemic patients with a perfluorochemical oxygen-transport fluid, Fluosol-DA. N Engl J Med. 1982 Jul 29;307(5):277–283. doi: 10.1056/NEJM198207293070503. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES